
Join to View Full Profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-273-5573
Dr. Spyropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of New Mexico School of MedicineResidency, Internal Medicine, 1992 - 1995
- Perelman School of Medicine at the University of PennsylvaniaClass of 1992
Certifications & Licensure
- NY State Medical License 2011 - 2027
- NM State Medical License 1993 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
Publications & Presentations
PubMed
- A Risk Assessment Model for Predicting Perioperative Venous Thromboembolism in Patients receiving surgery under anesthesia care.Aline M Grimm, Felix Borngaesser, Fran Ganz-Lord, Annika Bald, Peter Shamamian
Anesthesiology. 2025-04-03 - Perioperative Management of Direct Oral Anticoagulants in Patients having a High-Bleed-Risk Surgery or Neuraxial Procedure: The PAUSE-2 Pilot Randomized Trial.James D Douketis, Na Li, Melanie St John, Joanne Nixon, Karen Moffat
Journal of Thrombosis and Haemostasis. 2025-03-12 - Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study.Joseph R Shaw, Na Li, Matthieu Grussé, Patrick Van Dreden, Melanie St John
Thrombosis and Haemostasis. 2025-02-11
Journal Articles
- Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationAlex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis
Abstracts/Posters
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) StudyAlex Spyropoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...Alex C. Spyropoulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Feinstein Institutes Research Suggests New Management Protocols for Patients Taking Oral AnticoagulantsSeptember 11th, 2024
- When to Stop DOAC Before Urologic SurgeryAugust 26th, 2024
- COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes StudyMay 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: